Skip to content

4Accepted Aug 28, 5:00 PM ET

Bausch Christoph Lawrence 4

SABSSAB Biotherapeutics, Inc.

sec.gov(opens the filing on sec.gov)View full filing

Accepted (ET)

5:00 PM

Aug 28, 2025

Filed

Aug 28, 2025

Documents

1

Size

5.9 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.